XMU-MP-1
|
|
- CAS-Nr.
- 2061980-01-4
- Englisch Name:
- XMU-MP-1
- Synonyma:
- 4-((5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino)benzenesulfonamide;CS-2590;XMU-MP-1;XUM-MP- 1;PubChem ID: 121499143;XMU MP 1,Inhibitor,Hippo (MST),inhibit,XMUMP1;4-[(6,10-Dihydro-5,10-dimethyl-6-oxo-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide;Benzenesulfonamide, 4-[(6,10-dihydro-5,10-dimethyl-6-oxo-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]-
- CBNumber:
- CB63122127
- Summenformel:
- C17H16N6O3S2
- Molgewicht:
- 416.48
- MOL-Datei:
- 2061980-01-4.mol
|
XMU-MP-1 Eigenschaften
- Siedepunkt:
- 714.8±70.0 °C(Predicted)
- Dichte
- 1.523±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- L?slichkeit
- ≥41.6 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH
- Aggregatzustand
- powder
- pka
- 9.77±0.12(Predicted)
- Farbe
- white to beige
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
Sicherheit |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
XMU-MP-1 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
XMU-MP-1 is an inhibitor of the pro-apoptotic, sterile 20-like kinases MST1 and 2 (IC
50s = 71.1 and 38.1 nM, respectively). It is selective for MST1 and 2 over a panel of 468 kinases at a concentration of 1 μM. XMU-MP-1 inhibits phosphorylation of MOB1, LATS1 and 2, and YAP in HepG2 cells as well as MST1 and 2 autophosphorylation in RAW 264.7, U2OS, SW480, RPE1, SNU423, and HepG2 cells in a concentration-dependent manner. It also prevents cell death induced by overexpression of MST2. XMU-MP-1 (1 mg/kg) enhances liver regeneration in mice post partial hepatectomy and reduces liver fibrosis in a mouse model of chronic liver injury.
Verwenden
XMU-?MP-?1 an MST1/2 inhibitor.
XMU-MP-1 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
XMU-MP-1 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 80)Lieferanten
- XMU-MP-1
- PubChem ID: 121499143
- CS-2590
- 4-[(6,10-Dihydro-5,10-dimethyl-6-oxo-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide
- Benzenesulfonamide, 4-[(6,10-dihydro-5,10-dimethyl-6-oxo-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]-
- 4-((5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino)benzenesulfonamide
- XMU MP 1,Inhibitor,Hippo (MST),inhibit,XMUMP1
- XUM-MP- 1
- 2061980-01-4
- API